‘I’m Not Quite Sure How to Respond to This Presentation’
Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) - EurekAlert!
